The State of Metabolic Health in America, 2026 Baseline Edition · James M. Knox · DOI: 10.5281/zenodo.22772957 · Last reviewed: October 2026

Metabolic syndrome prevalence

Metric MH-07 · Series MH: America's Metabolic Health

Metabolic syndrome prevalence was 38.5% in 2023, according to CDC, NHANES.

This figure is reported as Metric MH-07 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).

Definition

This metric measures metabolic syndrome prevalence among u.s. adults. The unit of measurement is percent of adults. The geographic scope is United States.

Requires several risk factors to be present together by clinical definition.

Current Value

ValueData YearPopulationGeography
38.5%2023U.S. adultsUnited States

Source

CDC, NHANES.

Methodological Notes

This figure is drawn from CDC, NHANES. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.

See Methodology and Sources for the full source selection criteria and conflict resolution approach.

Cite This Metric

Metabolic syndrome prevalence, Metric MH-07. In Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

Last reviewed: October 2026

How to cite this page

Metabolic syndrome prevalence, Metric MH-07. In Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957

© 2026 James M. Knox. Figures may be reproduced with attribution: Knox, J. M. (2026). The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report. Zenodo. https://doi.org/10.5281/zenodo.22772957 ISSN 3144-8178 (Online)